Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imaging Synapses With [11C] UCB-J in Schizophrenia
NCT04038840Phase 1Recruiting
- Start
- Aug 2019
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of 11C-UCB-J (2 arms). Primary endpoint: Cross-sectional differences in synaptic density between HC and SZ participants at 120 minutes. Started Aug 2019; status: recruiting.
02
Drugs
11C-UCB-J
Beyond the preview
Go deeper on NCT04038840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04038840.